Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension, August 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 217 articles: HTML format

Single Articles

1. HARUTYUNOVA S, Heinz J, Benjamin N, Bruckner L, et al
   Effects of riociguat on right ventricular size and function in pulmonary arterial hypertension (RIVER II): a prospective, phase IV study.
   Respir Res. 2026;27:296.
   PubMed    
   Abstract available
   
   

2. OMUR SE, Zorlu C, Karayakali M, Karaman K, et al
   Admission electrocardiographic markers of atrial cardiomyopathy predict persistent pulmonary hypertension and chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a retrospective cohort study.
   J Thromb Thrombolysis. 2026 Jul 31. doi: 10.1007/s11239-026-03375.
   PubMed    
   Abstract available
   
   

3. SHE W, She M, Sun T
   Comment on: 'Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study'.
   Eye (Lond). 2026 Jul 31. doi: 10.1038/s41433-026-04378.
   PubMed    
   
   
   

4. AYALASOMAYAJULA S, Bajwa EK, Cornell AG, Loureiro MJ, et al
   The Evolving Landscape of Pulmonary Hypertension Treatment: From Vasodilation to Disease Modification.
   Clin Transl Sci. 2026;19:e70685.
   PubMed    
   Abstract available
   
   

5. LIANG J, Xie Y, Su D, Pang Y, et al
   Post-translational modification crosstalk in pulmonary arterial hypertension: mechanisms and therapeutic implications.
   Mol Biol Rep. 2026;53:1308.
   PubMed    
   Abstract available
   
   

6. WANG L, Cui Y, Song J, Zhao Q, et al
   Pseudo-Infarction Reversal in Right Precordial Leads: ECG Evolution in Severe Pulmonary Hypertension.
   JACC Case Rep. 2026;31:109342.
   PubMed    
   Abstract available
   
   

7. DUIJNHOUWER AL, Hagmolen Of Ten Have W, Van Haren-Willems J, Knaapen-Hans H, et al
   Apparent nonadherence to risk-guided therapy in pulmonary hypertension: The role of clinical complexity in real-world practice.
   Respir Med Res. 2026;90:101306.
   PubMed    
   Abstract available
   
   

8. KAMENSKI-RATHMANNER T, Tornyos A, Brcic L, Talakic E, et al
   Pulmonary hypertension in patients with moderate to severe hypersensitivity pneumonitis.
   Respiration. 2026 Jul 29:1-19. doi: 10.1159/000553575.
   PubMed    
   Abstract available
   
   

9. VILLANUEVA LM, Ito H, Qi X, Chapoval SP, et al
   Absence of insulin receptor substrate 2 (IRS2) in myeloid cells results in enhanced hypoxia-induced remodeling of the pulmonary vasculature and heart with modest effects on allergic lung inflammation.
   Immunohorizons. 2026;10:vlag028.
   PubMed    
   Abstract available
   
   

10. MOHIADDIN H, Mohee K, Ambrogetti R, Bhandari SS, et al
    Does severe pulmonary hypertension affect long-term survival after TAVI for severe aortic stenosis?
    Br J Cardiol. 2026;33:003.
    PubMed    
    Abstract available
    
    

11. YU Q, Zhao Y, Huang Y, Zhang M, et al
    Identification of pulmonary hypertension with pulmonary vascular surface volume ratio by non-contrast CT.
    BMC Cardiovasc Disord. 2026;26:641.
    PubMed    
    Abstract available
    
    

12. HUANG A, Pan T, Gao Y, Ji G, et al
    Construction of nomogram for predicting pulmonary hypertension on echocardiography in chronic obstructive pulmonary disease: a single-center retrospective study.
    Open Med (Wars). 2026;21:20261475.
    PubMed    
    Abstract available
    
    

13. JUMATATE R, Labaf A, Ingvarsson A, Johansson M, et al
    Right ventricular longitudinal function is associated with exercise capacity in pre-capillary pulmonary hypertension: a multimodality imaging study.
    Eur Heart J Imaging Methods Pract. 2026;4:qyag116.
    PubMed    
    Abstract available
    
    

14. GHERBESI E, Faggiano A, Cuspidi C
    The Electrocardiogram and Pulmonary Hypertension: When Occam'S Razor Fails.
    Echocardiography. 2026;43:e70577.
    PubMed    
    
    
    

15. MICKAEL C, Fonseca Balladares DC, Kumar R, Lee MH, et al
    Role of CD4 T cell mannose binding lectin in Schistosoma-induced pulmonary hypertension.
    JCI Insight. 2026 Jul 28:e202919. doi: 10.1172/jci.insight.202919.
    PubMed    
    Abstract available
    
    

16. CHEN Z, Ge D, Li X, Wei TW, et al
    AMPK/USP10 loop activation of ACE2: implications for pulmonary hypertension.
    Eur Heart J. 2026 Jul 28:ehag568. doi: 10.1093.
    PubMed    
    Abstract available
    
    

17. LUO X, Xiong X, Li J, Luo J, et al
    The Level and Clinical Significance of Red Blood Cell Distribution Width in Patients With Congenital Heart Disease Associated With Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70339.
    PubMed    
    Abstract available
    
    

18. YOGESWARAN A, Funderich M, Wendlandt K, Annis JS, et al
    Angiotensin Converting Enzyme Inhibition and Mortality in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD).
    Pulm Circ. 2026;16:e70348.
    PubMed    
    Abstract available
    
    

19. DAGHER C, Moallem N, Fiscus G, Carollo B, et al
    Noninvasive Gas Exchange Determinants of Exercise Hemodynamics in Non-Severe Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Pulm Circ. 2026;16:e70358.
    PubMed    
    Abstract available
    
    

20. SUZUKI Y, Nakano Y, Okazaki K, Ito M, et al
    Long-Term Supervised Cardiac Rehabilitation After Balloon Pulmonary Angioplasty Improved Residual Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Two-Case Report.
    Pulm Circ. 2026;16:e70359.
    PubMed    
    Abstract available
    
    

21. RAJAGOPAL S, Abueg J, Hart KM, Lau E, et al
    Activin Signaling Inhibitors in Pulmonary Hypertension: A State-of-the-Art Review.
    Pulm Circ. 2026;16:e70353.
    PubMed    
    Abstract available
    
    

22. REISER AE, Thiersch M, Gassmann M, Schneider SR, et al
    Iron Homeostasis at High Altitude in Patients With Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70352.
    PubMed    
    Abstract available
    
    

23. MCGARRITY S, Johansson PI, Carlsen J
    Metabolic Markers as Potential Risk Factors in Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70342.
    PubMed    
    Abstract available
    
    

24. YUE J, Wang P, Liu H, Pei H, et al
    Poncirin Alleviates Hypoxic Pulmonary Hypertension by Blocking TDP43-Mediated Macrophage Pyroptosis.
    Pulm Circ. 2026;16:e70368.
    PubMed    
    Abstract available
    
    

25. CHEN K, Li L, Huang Y, Ye L, et al
    The Role of Piezo Ion Channels in Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70360.
    PubMed    
    Abstract available
    
    

26. KARIM R, Fyrdahl A, Ramos JG, Melin M, et al
    The Relationship Between Vortical Flow and Pressure Gradient Reversal in Pulmonary Hypertension-A 4D Analysis of Cardiovascular Magnetic Resonance Flow Imaging.
    Pulm Circ. 2026;16:e70350.
    PubMed    
    Abstract available
    
    

27. ALQARNI AA, Aljedani RH, Aldhahir AM, Alasimi AH, et al
    The Therapeutic Efficacy of Drugs Targeting the NO-sGC-cGMP Pathway in Treatment of Patients With Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review.
    Pulm Circ. 2026;16:e70337.
    PubMed    
    Abstract available
    
    

28. RAWLINGS GH, Armstrong I, Thompson AR, Kiely DG, et al
    Getting the Wheels in Motion to Deal With Unmet Psychological Need: A Reply to "The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of Life".
    Pulm Circ. 2026;16:e70356.
    PubMed    
    
    
    

29. MOREL KC, Sood N, Bernardo R, Jackson K, et al
    Navigating the Complexities of Pulmonary Hypertension Care: Unique Challenges in PAH Management.
    Pulm Circ. 2026;16:e70340.
    PubMed    
    Abstract available
    
    

30. KARKOULIAS S, Leontsinis I, Iliakis P, Kallenou L, et al
    Repurposing Heart Failure Therapies in Pulmonary Arterial Hypertension: Mechanistic Rationale, Translational Evidence, and Clinical Perspectives for SGLT2 Inhibitors and Mineralocorticoid Receptor Antagonists.
    Medicina (Kaunas). 2026;62:1345.
    PubMed    
    Abstract available
    
    

31. HU L, Zhao Q, Zhao Z, Luo Q, et al
    Retrospective Evaluation of Recombinant Human Brain Natriuretic Peptide Therapy for Decompensated Right Heart Failure Across Pulmonary Hypertension Groups.
    Medicina (Kaunas). 2026;62:1213.
    PubMed    
    Abstract available
    
    

32. QI Y, Ma K, Han X, Xu D, et al
    Temporal Convolutional Neural Network Analysis of Magnetocardiography Signals for Detection of Pulmonary Hypertension.
    Bioengineering (Basel). 2026;13:736.
    PubMed    
    Abstract available
    
    

33. ZHONG D, Gao W, Ren J, Yang L, et al
    Vasoactive-Inotropic Score and in-hospital mortality in preterm infants < 34 weeks' gestation with early pulmonary hypertension in the setting of respiratory distress and sepsis.
    J Matern Fetal Neonatal Med. 2026;39:2705051.
    PubMed    
    Abstract available
    
    

34. TUTTLE M, Ruopp NF, Sarnak MJ
    Pulmonary Hypertension, Right Ventricular Remodeling and Outcomes in Chronic Kidney Disease.
    Clin J Am Soc Nephrol. 2026 Jul 27. doi: 10.2215/CJN.0000001198.
    PubMed    
    Abstract available
    
    

35. YE Y, Wang H, Lan Y, Pan W, et al
    Uric Acid-to-Albumin Ratio as a Complementary Biomarker for In-Hospital Risk Stratification in Patients with Pulmonary Hypertension: A Retrospective Cohort Study.
    J Cardiovasc Dev Dis. 2026;13:295.
    PubMed    
    Abstract available
    
    

36. HUANG C, Bai J, Luo A, Yang L, et al
    Omaveloxolone Driven NRF2 Activation as a Novel Therapeutic Strategy for Pulmonary Hypertension.
    Hypertension. 2026 Jul 27. doi: 10.1161/HYPERTENSIONAHA.126.26711.
    PubMed    
    Abstract available
    
    

37. NWOKEOCHA SO, Abduova L, Thiruvarudchelvam S, Chaudhary A, et al
    Pre-Capillary Pulmonary Hypertension in a Patient With Idiopathic Inflammatory Myopathy Without Extensive Pulmonary Involvement.
    Am J Case Rep. 2026;27:e953110.
    PubMed    
    Abstract available
    
    

38. KUCUK M, Zablah JE, Fleming G, Vanloozen D, et al
    Performance of the Occlutech(R) Atrial Flow Regulator Device in Patients With Either Failing Fontan Circulations or Irreversible Pulmonary Hypertension.
    Catheter Cardiovasc Interv. 2026 Jul 26. doi: 10.1002/ccd.70776.
    PubMed    
    Abstract available
    
    

39. GUIMARON S, Mercier J, Hautbergue T, Ruffenach G, et al
    Right ventricular remodeling and circulating metabolic profiles of patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy.
    JHLT Open. 2026;13:100618.
    PubMed    
    Abstract available
    
    

40. MUKHERJEE M, Hassoun PM
    Metabolism beyond mechanics: Revisiting right ventricular adaptation in pulmonary hypertension.
    J Nucl Cardiol. 2026;61:102792.
    PubMed    
    
    
    

41. LAMA E, Wang Y, Wu J, Ma Q, et al
    Pathophysiological mechanisms and therapeutic potential of E-selectin in pulmonary arterial hypertension.
    Front Immunol. 2026;17:1754940.
    PubMed    
    Abstract available
    
    

42. MERC P, Demir R, Zeren M, Durdu H, et al
    Reliability and validity of the Turkish version of the Barthel Index-dyspnea in patients with pulmonary hypertension.
    Turk J Med Sci. 2026;56:794-800.
    PubMed    
    Abstract available
    
    

43. LUO XY, Li XC, Fu X, Tian YY, et al
    Endoplasmic Reticulum Stress-Induced Endothelial Cell Pyroptosis Contributes to Pulmonary Vascular Remodeling and Pulmonary Arterial Hypertension via IRE1alpha/Caspase-3/GSDME Pathway.
    J Am Heart Assoc. 2026;15:e043577.
    PubMed    
    Abstract available
    
    

44. D'HUMIERES T, Jeune SL, de Luna G, Moulin T, et al
    The many facets of cardiopulmonary complications in sickle cell disease.
    Semin Hematol. 2026;63:16-27.
    PubMed    
    Abstract available
    
    

45. LU XT, Chen XR, Jin Q, Xu YY, et al
    Maternal and fetal outcomes in patients with congenital heart disease associated with pulmonary arterial hypertension in high-altitude areas: a retrospective cohort study.
    BMC Pregnancy Childbirth. 2026;26:818.
    PubMed    
    Abstract available
    
    

46. ZINELLU E, Piras B, Di Lorenzo B, Albrahimi E, et al
    A Retrospective Analysis of Risk Factors for Respiratory Failure in Silicosis Patients Exposed to Granite Dust.
    J Occup Environ Med. 2026;68:e560-e564.
    PubMed    
    Abstract available
    
    

47. TEMPEL L, Schrepper A, Berndt A, Schulze PC, et al
    Longitudinal progression of tissue remodeling in experimental pulmonary hypertension is accompanied by a continuously increasing re-expression of extra domain A-containing fibronectin.
    Histochem Cell Biol. 2026;164:74.
    PubMed    
    Abstract available
    
    

48. DEB G, Emmanuel J, Bacon JL, Wong S, et al
    Multidisciplinary Management of the Rare Coexistence of Multiple Endocrine Neoplasia Type 1 and Chronic Thromboembolic Pulmonary Hypertension: A Case Report.
    Cureus. 2026;18:e114115.
    PubMed    
    Abstract available
    
    

49. BUBER I, Heerdt P, Singh I, Sevgican CI, et al
    Right Ventricular to Left Ventricular (RV/LV) Blood Pool T2 Ratio Is Associated With Invasive Hemodynamics Across Pulmonary Hypertension Subgroups.
    Pulm Circ. 2026;16:e70381.
    PubMed    
    Abstract available
    
    

50. ROUSSET MC, Sullivan RT, Brown AM, Eagle SR, et al
    The Heterogeneity of Long-Term Cardiopulmonary Outcomes in Children Born Preterm May Benefit from Pulmonary Hypertension-Specialty Outpatient Follow-Up.
    Pulm Circ. 2026;16:e70380.
    PubMed    
    Abstract available
    
    

51. JABEEN M, Younas S, Majid A, Fatima H, et al
    Left Atrial Myopathy as a Phenotypic Axis in HFpEF: Implications for Pulmonary Hypertension, Exercise Intolerance, and Targeted Therapy.
    Cardiol Rev. 2026 Aug 8. doi: 10.1097/CRD.0000000000001423.
    PubMed    
    Abstract available
    
    

52. RODENBURG TC, Boerman S, Post M, Bogaard HJ, et al
    STOP-RIO study: protocol for a randomised, controlled, open-label non-inferiority trial to test the safety of discontinuation of riociguat after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    BMJ Open. 2026;16:e120820.
    PubMed    
    Abstract available
    
    

53. QIN S, Shang L, Su D, Ye B, et al
    Development and validation of a nomogram prediction model for mild pulmonary arterial hypertension risk in children with left-to-right shunt congenital heart disease.
    Medicine (Baltimore). 2026;105:e50136.
    PubMed    
    Abstract available
    
    

54. KWAN LT, Del Mundo RJS, McCown ME, Fremed MA, et al
    Estimating Exercise Intensity Using Heart Rate Methods in Children and Young Adults with Pulmonary Hypertension.
    Pediatr Cardiol. 2026 Aug 7. doi: 10.1007/s00246-026-04411.
    PubMed    
    Abstract available
    
    

55. XIAOTONG G, Yuchun F, Ting J, Xia C, et al
    Role of alpha-SMA, NOX4, Fibronectin, and HIF-1alpha in Pulmonary Microvascular Remodeling in COPD Patients Without Pulmonary Arterial Hypertension.
    Clin Respir J. 2026;20:e70218.
    PubMed    
    Abstract available
    
    

56. SAMUSHIYA MA, Klyushnik TP, Zateyshchikov DA, Tertyshnik AM, et al
    [The biological role of neuroinflammation in the pathogenesis of mental disorders associated with pulmonary hypertension].
    Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126:7-14.
    PubMed    
    Abstract available
    
    

57. GENC HZ, Ceylan H, Kamali H, Recep E, et al
    Clinical effects of persistent pulmonary hypertension in newborns diagnosed with transposition of the great arteries.
    Front Cardiovasc Med. 2026;13:1888066.
    PubMed    
    Abstract available
    
    

58. TAGER D, Raeisi-Giglou P, Naal T, Jawad A, et al
    Sitting Challenge During Right Heart Catheterisation in Adults with Postcapillary Pulmonary Hypertension.
    Heart Lung Circ. 2026 Aug 6:S1443-9506(26)00201.
    PubMed    
    
    
    

59. NAGAYOSHI S, Fujii S, Shimizu Y, Miyamoto T, et al
    Mechanical thrombus removal using biopsy forceps for recurrent CTO reocclusion in chronic thromboembolic pulmonary hypertension.
    AsiaIntervention. 2026;12:e164-e165.
    PubMed    
    
    
    

60. ZHU H, Li B, Wang X, Huang L, et al
    Mechanistic investigation of Midkine-Notch2 signaling in suppressing pulmonary artery smooth muscle cell apoptosis and promoting vascular remodeling in hypoxic pulmonary hypertension.
    Front Pharmacol. 2026;17:1788582.
    PubMed    
    Abstract available
    
    

61. GODINAS L, Gerges C, Revel MP, Prokop M, et al
    ESR Bridges: chronic thromboembolic pulmonary hypertension: new developments in imaging and treatment-a multidisciplinary view.
    Eur Radiol. 2026 Aug 5. doi: 10.1007/s00330-026-12781.
    PubMed    
    
    
    

62. XIAO QX, Li JJ, Ding YJ, Li QY, et al
    [Early efficacy and safety of sotatercept in the treatment of pulmonary arterial hypertension in a Chinese population: a single-center case series analysis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2026;49:834-839.
    PubMed    
    Abstract available
    
    

63. PRINS SE, Blake MJ, Helke KL, Di Salvo T, et al
    Large animal models of right heart failure due to pulmonary hypertension: a bridge to translational success.
    Eur Respir Rev. 2026;35:260015.
    PubMed    
    Abstract available
    
    

64. ZHANG MJ, Bo YC, Shi JZ, Xu MD, et al
    The association of cardiovascular health with new-onset pulmonary hypertension and the mediating role of proteomic signatures.
    J Hypertens. 2026 Jul 28. doi: 10.1097/HJH.0000000000004409.
    PubMed    
    Abstract available
    
    

65. NASCIMENTO I, Fernandes CJCDS
    How should patient knowledge trigger clinical action in artificial intelligence-enabled pulmonary hypertension care?
    Eur Heart J Digit Health. 2026;7:ztag123.
    PubMed    
    
    
    

66. PANDE SA, Chan Joiner H, Szafranski P, Gambin T, et al
    Complex Genomic Rearrangement Involving the TBX4 Promoter Manifesting With Variable Expressivity in a Five-Generation Family.
    Hum Mutat. 2026;2026:7278477.
    PubMed    
    Abstract available
    
    

67. AGUADO B, Lacoste-Palasset T, Favard F, Palat S, et al
    A Proof of Concept for the Use of Lung Ultrasound in the Diagnostic Approach of Pulmonary Hypertension.
    CHEST Pulm. 2025;4:100225.
    PubMed    
    
    
    

68. SCHWALBACH KT, Annis J, Garry JD, Nian H, et al
    Incidence and Clinical Associations With Phenotypic Drift From Pulmonary Arterial Hypertension to Combined Precapillary and Postcapillary Pulmonary Hypertension.
    CHEST Pulm. 2025;3:100206.
    PubMed    
    Abstract available
    
    

69. ROJAS A, Morales DLS, Wikenheiser-Brokamp KA, Hayes D Jr, et al
    Unusual Clinical Course of Pediatric Pulmonary Hypertension with Underlying SOX17 Mutation.
    Ann Am Thorac Soc. 2026 Aug 3:aaoag216. doi: 10.1093.
    PubMed    
    
    
    

70. SHEN L, Ma H, Yu Y, Xu Y, et al
    Inhibiting HIF-1alpha-Induced miR-663b Improves Pulmonary Arterial Hypertension by Reducing Dysfunctions of PASMCs Through Repressing Sirt1-ZBP1-Mediated PANoptosis.
    J Cell Mol Med. 2026;30:e71285.
    PubMed    
    Abstract available
    
    

71. WHITE YN, Douglass M, Cathcart R, Van Boerum J, et al
    Echocardiography Assessment of Cardiac Function and Pulmonary Hypertension in Lambs.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available
    
    

72. FAIZ A, Gulalai W
    Pulmonary hypertension in beta-thalassaemia: methodological considerations and future directions.
    Acta Cardiol. 2026 Aug 3:1-2. doi: 10.1080/00015385.2026.2712732.
    PubMed    
    
    
    

73. XIONG J, Zhai Y, Yu A, Wang L, et al
    Mediating Effects of Fear of Movement and Self-Efficacy Between Illness Perception and Health-Related Quality of Life in Pulmonary Hypertension.
    Psychol Res Behav Manag. 2026;19:617450.
    PubMed    
    Abstract available
    
    

74. MICHAEL A, Abdallah RJ, Ogiator AB, Ejideh AO, et al
    Use of Oral Sildenafil in the Management of Persistent Pulmonary Hypertension of the Newborn: A Case Report and Review of Literature.
    Niger Med J. 2026;67:364-370.
    PubMed    
    Abstract available
    
    

75. PELLONI F, De Perna ML, Moschovitis G
    Pulmonary Hypertension in a 19-Year-Old Patient Due to a Mutation in the Bone Morphogenetic Protein Receptor Gene: A Case Report.
    Cureus. 2026;18:e111973.
    PubMed    
    Abstract available
    
    

76. PARIMI VP, Tejaswini RN
    A Complex Case of Systemic Sclerosis with Concurrent Breast Malignancy and Treatment-related Complications.
    J Assoc Physicians India. 2026;74.
    PubMed    
    Abstract available
    
    

77. PUTORTI F, Fabris T, Mesiani C, Tripi S, et al
    Right ventricular-pulmonary artery uncoupling identifies higher risk of combined pulmonary hypertension in patients undergoing TAVR.
    Cardiovasc Ultrasound. 2026;24:17.
    PubMed    
    Abstract available
    
    

78. KOTHARI SS
    Risk stratification in post operative pulmonary hypertension: Insights from the the japanese association of congenital heart disease registry (JACPHR) members.
    Am Heart J Plus. 2026;69:100840.
    PubMed    
    
    
    

79. SHAHANE S, Acharya S, Challawar R, Unas J, et al
    Fulminant Pulmonary Hypertension Due to Pulmonary Lymphangitic Carcinomatosis and Tumor Embolism From Occult Pulmonary Adenocarcinoma.
    Cureus. 2026;18:e111909.
    PubMed    
    Abstract available
    
    

80. BHARTI D, Kolodiazhna T, Kacar S, Varghese MV, et al
    Poly-Pharmacologic Disruption of the Proliferative-to-Mesenchymal Fate Branch Point Reverses EndMT and Pulmonary Hypertension.
    Res Sq [Preprint]. 2026 Jul 23:rs.3.rs-9306408. doi: 10.21203/rs.3.rs-9306408.
    PubMed    
    Abstract available
    
    

81. WEERASEKARE JM, Rosen J, Kopras EJ, Elwing J, et al
    Pulmonary Hypertension Training in Pulmonary & Critical Care Medicine Fellowship: A National Survey.
    ATS Sch. 2026 Jul 31:aapag040. doi: 10.1093.
    PubMed    
    Abstract available
    
    

82. GREEN JL, Costin V, Armstrong I, Thompson AR, et al
    How Do Sleep Difficulties Interact With Anxiety, Depression and Health-Related Quality of Life in Pulmonary Hypertension?
    Clin Respir J. 2026;20:e70220.
    PubMed    
    Abstract available
    
    

83. YOSHIDA K, Toth E, Duijvelaar E, Neep B, et al
    Empagliflozin Ameliorates Experimental Pulmonary Vascular Remodeling, but May Not Benefit Patients With Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2026;15:e047945.
    PubMed    
    Abstract available
    
    

84. SHI JZ, Ye JS, An XR, Cheng G, et al
    Metabolic reprogramming in pulmonary arterial hypertension.
    Pharmacol Ther. 2026;286:109085.
    PubMed    
    Abstract available
    
    

85. TSOI SM, Gasper C, Maltepe E, Chidboy MA, et al
    Placental abnormalities of malperfusion, inflammation, and meconium are associated with neonatal pulmonary vascular disease.
    Placenta. 2026;182:341-347.
    PubMed    
    Abstract available
    
    

86. REN H, Ding N, Yu X, Teng J, et al
    Lung disease in adult-onset Still's disease: a Chinese cohort study.
    Rheumatology (Oxford). 2026;65:keag375.
    PubMed    
    Abstract available
    
    

87. ALDALAAN A, Nadeef S, Khouj E, Alahmadi F, et al
    An Ancient Founder GDF2 Variant Potentially Causes Semi-Dominant Non-Syndromic Pulmonary Arterial Hypertension.
    Clin Genet. 2026;110:289-298.
    PubMed    
    Abstract available
    
    

88. JI H, Ma S, Bao W, Li X, et al
    Transcriptomic analysis identifies novel ferroptosis-related biomarkers and therapeutic targets in pulmonary arterial hypertension.
    J Hypertens. 2026 Jun 11. doi: 10.1097/HJH.0000000000004374.
    PubMed    
    Abstract available
    
    

89. HAO Y, Montes R, Oon S, Nikpour M, et al
    Management of inflammatory cardiopulmonary manifestations in systemic lupus erythematosus: a systematic review.
    Adv Rheumatol. 2026;66:47.
    PubMed    
    Abstract available
    
    

90. FAUVEL C, Jaque PC, Liu Y, Lee SW, et al
    Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and Mortality.
    JACC Heart Fail. 2026;14:103151.
    PubMed    
    Abstract available
    
    

91. ABOABAT A, Al-Hammad A, Alhussin A, AlQutub S, et al
    Real-World Adherence to Systemic Sclerosis Quality Indicators: A Single-Center Quality of Care Study.
    J Rheumatol. 2026;53:894-898.
    PubMed    
    Abstract available
    
    

92. SADOWSKA-KRAWCZENKO I, Hozejowski R, Mazela J, Wroblewska-Seniuk K, et al
    Pulmonary comorbidities and response to surfactant in late preterm infants: a multicenter cohort study.
    Pediatr Res. 2025 Dec 1. doi: 10.1038/s41390-025-04634.
    PubMed    
    Abstract available
    
    

93. WANG L, Mao Z, Zheng P, Zi G, et al
    Assessment of Riociguat-related adverse events: a disproportionality analysis utilizing the FDA adverse event reporting system database.
    Expert Opin Drug Saf. 2026;25:1553-1566.
    PubMed    
    Abstract available
    
    

94. WANG Q, Luo F, Xiong X, Zhang B, et al
    Association between serum oxidative stress-related biomarkers and right ventricular function and their predictive value in PAH: A single-cohort study.
    Medicine (Baltimore). 2026;105:e50196.
    PubMed    
    Abstract available
    
    

95. KOHN S, Evans M, Itani R, Wang S, et al
    Prevalence of pulmonary hypertension in children with Prader-Willi Syndrome.
    Sleep Med. 2026;148:109190.
    PubMed    
    Abstract available
    
    

96. YU W, Luo Y, Zhu S, Lai Y, et al
    Intravascular ultrasound analysis of spontaneous pulmonary artery lumen enlargement after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
    Front Med (Lausanne). 2026;13:1899355.
    PubMed    
    Abstract available
    
    

97. MISMETTI V, Montani D, Bertoletti L
    Pulmonary rehabilitation in COPD with suspected pulmonary hypertension: a step toward.
    Respir Med Res. 2026;90:101309.
    PubMed    
    
    
    

98. TAKAJO D, Critser PJ, Hirsch R
    Impact of Thermodilution on Indexed Pulmonary Vascular Resistance Calculations in Pediatric Pulmonary Arterial Hypertension.
    Pediatr Pulmonol. 2026;61:e71787.
    PubMed    
    Abstract available
    
    

99. VASARMIDI E, Calaras D, Kourouni I, Perelas A, et al
    Navigating the Complexity of PH-ILD: From Molecular Mechanisms to Integrated Clinical Evaluation.
    Int J Mol Sci. 2026;27:7055.
    PubMed    
    Abstract available
    
    

100. GONZALEZ-HERMOSILLO LM, Cueto-Robledo G, Gaytan-Cervantes J, Navarro-Vergara DI, et al
     Methylation in the TAC1 Gene Promoter Is Associated with the Transition from Acute Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension.
     Int J Mol Sci. 2026;27:6913.
     PubMed    
     Abstract available
     
     

101. KHAN A, Ullah Z, Sheraz M, Noor H, et al
     Disparity trends in coexisting renal failure- and pulmonary hypertension-related mortality in the United States (1999-2020): CDC WONDER database study.
     Ann Med Surg (Lond). 2026;88:5195-5203.
     PubMed    
     Abstract available
     
     

102. ZHANG M, Xiao Y, Guo W, Wang Y, et al
     Clinical characteristics of pulmonary hypertension associated with hereditary hemorrhagic telangiectasia treated with bevacizumab: a single-center case series.
     J Thorac Dis. 2026;18:763.
     PubMed    
     Abstract available
     
     

103. DUQUE-RESTREPO D, Ramirez-Arboleda PE, Escobar-Matallana JJ, Saldarriaga-Giraldo C, et al
     Bilateral coronary-pulmonary artery fistulas presenting with new-onset heart failure and pulmonary hypertension.
     J Cardiol Cases. 2026;34:43-45.
     PubMed    
     Abstract available
     
     

104. PATA R, Kristeva J, Illies M, Stocks J, et al
     A Breath of Life Beyond Bronchodilation: Early Data on Hemodynamic and Functional Outcomes With Ensifentrine Nebulization in Severe COPD-associated Pulmonary Hypertension.
     Open Respir Med J. 2026;20:e18743064456019.
     PubMed    
     Abstract available
     
     

105. RECCARDINI N, Da Re B, Mondini L, Salton F, et al
     Exploring the therapeutic landscape of pulmonary hypertension associated with interstitial lung disease, with a focus on idiopathic pulmonary fibrosis: a narrative review.
     Front Pharmacol. 2026;17:1865787.
     PubMed    
     Abstract available
     
     

106. XIAO R, Li B, Ming Y, Zhao R, et al
     Quantitative imaging features of pulmonary artery involvement in Takayasu arteritis on computed tomography pulmonary angiography in patients with and without pulmonary hypertension.
     Quant Imaging Med Surg. 2026;16:633.
     PubMed    
     Abstract available
     
     

107. JEVNIKAR M, Macisaac S, Brenot P, Lionnet F, et al
     Efficacy and safety of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension associated with sickle cell disease.
     Respir Med Res. 2026;90:101308.
     PubMed    
     Abstract available
     
     

108. ALDAKAK MA, Deeb A, Wasel N
     Transaortic repair of a large aortopulmonary window with concomitant mitral valve repair in an infant with systemic pulmonary hypertension: a case report.
     Int J Surg Case Rep. 2026;138:3177-3182.
     PubMed    
     Abstract available
     
     

109. HAN Y, Zhang H, Zhang J
     Correction: Altered early-life gut microbiota in offspring of pregnancies complicated by CHD-associated pulmonary hypertension.
     Front Microbiomes. 2026;5:1932978.
     PubMed    
     Abstract available
     
     

110. FUJISAKI S, Kuraishi A, Takano R, Hayashi H, et al
     Methamphetamine-Associated Pulmonary Arterial Hypertension in a Japanese Pulmonary Hypertension Referral Center.
     Circ Rep. 2026;8:1367-1369.
     PubMed    
     Abstract available
     
     

111. VASHER ST, Khan A, Tsui K, Potter L, et al
     Bloodless bilateral lung transplant in a patient, a Jehovah's Witness, with pulmonary fibrosis and secondary pulmonary hypertension.
     JTCVS Tech. 2026;38:102447.
     PubMed    
     
     
     

112. WU R, Fu S, Zhang Y, Dong Y, et al
     Circadian clock-gut microbiota axis in pulmonary hypertension: linking gut-lung crosstalk, immune timing and vascular remodeling.
     Front Physiol. 2026;17:1895249.
     PubMed    
     Abstract available
     
     

113. YANG L, Zhong F, Zhang J, Ye Y, et al
     [Perioperative outcomes and anesthetic management of pregnancy termination in patients with pulmonary hypertension].
     Nan Fang Yi Ke Da Xue Xue Bao. 2026;46:1850-1860.
     PubMed    
     Abstract available
     
     

114. SHEN YY, Chen YB, Li X, Xu X, et al
     Genome-wide network analysis identifies the lncRNA-92467/miR-205-5p/PTPRM/CAMs axis in a rat model of hypoxic pulmonary hypertension.
     Animal Model Exp Med. 2026 Aug 10:10.1002/ame2.70267. doi: 10.1002/ame2.70267.
     PubMed    
     Abstract available
     
     

115. KLINGBEIL R, Hjalmarsson C, Colvin B, Kozarek K, et al
     Inhaled pulmonary vasodilators in pulmonary hypertension: Perioperative use and clinical considerations.
     JHLT Open. 2026;14:100627.
     PubMed    
     Abstract available
     
     

116. KANAI M, Tsuru H, Onuki T, Nukaga S, et al
     Pulmonary Hypertension with a High-Output Hemodynamic Profile in a Child with MELAS: A Case Report.
     Intern Med. 2026 Aug 8. doi: 10.2169/internalmedicine.7614.
     PubMed    
     Abstract available
     
     

117. GUO X, Gao C, Li L, Li Y, et al
     MYNN regulates hypoxia-induced PASMCs proliferation and migration by modulating the PDLIM1/NF-kappaB axis.
     Eur J Pharmacol. 2026;1031:179204.
     PubMed    
     Abstract available
     
     

118. ALTURAIF N, Alhammad S, Desai S, Alahmadi F, et al
     Phenotypic patterns and outcomes of connective tissue disease-associated pulmonary arterial hypertension: a Saudi single center experience.
     Respir Med. 2026;261:109051.
     PubMed    
     Abstract available
     
     

119. DIVYA A, Dalal N, Nandavaram S, Chia AXF, et al
     Sex-based differences in long-term respiratory and pulmonary vascular outcomes after acute pulmonary embolism: A propensity-matched analysis of 795,338 patients.
     Respir Med. 2026;261:109038.
     PubMed    
     Abstract available
     
     

120. LI S, Pan H, Wei L, Guo X, et al
     GDF11 regulates hypoxia-induced pulmonary endothelial cell pyroptosis through SOX2/NLRP3 axis.
     Eur J Pharmacol. 2026;1030:179112.
     PubMed    
     Abstract available
     
     

121. WANG S, Wang X, Miao L, Zhang Y, et al
     DKK1 activated the NF-kappaB pathway by binding with CKAP4 to induce PASMC oxidative stress and promote pulmonary arterial hypertension.
     Genes Genomics. 2026;48:1117-1130.
     PubMed    
     Abstract available
     
     

122. VU J, Zhabyeyev P, Brown KJ, Gorham J, et al
     Apelin analog treatment reverses severe pulmonary arterial hypertension and right ventricular heart failure.
     JCI Insight. 2026;11:e200684.
     PubMed    
     Abstract available
     
     

123. CHEN Y, Mao L, Fan Y, Xu H, et al
     PARK7 alleviates high-altitude pulmonary edema by suppressing BACH1 to attenuate lipid peroxidation-driven pro-inflammatory skewing of macrophages.
     Pathol Res Pract. 2026;286:156566.
     PubMed    
     Abstract available
     
     

124. WANG S, Yu L, Huang L, Liu X, et al
     Risk factors and outcomes of HPH in high-altitude residents via echocardiographic evaluation.
     BMC Cardiovasc Disord. 2026;26:681.
     PubMed    
     Abstract available
     
     

125. CHEN J, Liu D, Zhang J, Han W, et al
     Emergency donor pericardial conduit for ruptured pulmonary artery in lung transplantation for severe PH: a case report.
     J Cardiothorac Surg. 2026;21:532.
     PubMed    
     Abstract available
     
     

126. SHAVER D, Haworth S, Graumann E, Frizzell B, et al
     Characterization of Pulmonary Functional Abnormalities in Systemic Sclerosis Using Xenon MRI.
     J Magn Reson Imaging. 2026 May 6. doi: 10.1002/jmri.70363.
     PubMed    
     Abstract available
     
     

127. LINKUS T, Biggin D, Strickland B
     B-line Prevalence Is Higher with Increases in Altitude but Does Not Correlate with AMS Symptomatology.
     Wilderness Environ Med. 2026;37:378-384.
     PubMed    
     Abstract available
     
     

128. YUAN A, Bai Y, Jiang Y, Si S, et al
     The role and mechanism of rosiglitazone in endothelial-to-mesenchymal transition in pulmonary hypertension.
     Eur J Pharmacol. 2026 Aug 21:179227. doi: 10.1016/j.ejphar.2026.179227.
     PubMed    
     Abstract available
     
     

129. JIN K, Chen K, Magod BL, Meng Z, et al
     Safety and Feasibility of Same-Day Discharge After Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Single-Center Retrospective Study.
     J Soc Cardiovasc Angiogr Interv. 2026;5:105505.
     PubMed    
     Abstract available
     
     

130. EL-HINDI S
     Vardenafil efficacy for the treatment of persistent pulmonary hypertension of the newborn.
     World J Clin Pediatr. 2026;15:118862.
     PubMed    
     Abstract available
     
     

131. LV Q, Yao R, Cheng M
     Utility of serum HMGB1 in chronic obstructive pulmonary disease with pulmonary hypertension: A single-centre analysis.
     Pulmonology. 2026;32:2720837.
     PubMed    
     Abstract available
     
     

132. SUZUKI T, Kawai S, Tanaka S, Uchida H, et al
     Pulmonary Veno-Occlusive Disease Presenting as Congenital Heart Disease-Associated Pulmonary Hypertension.
     JACC Case Rep. 2026 Aug 20:109910. doi: 10.1016/j.jaccas.2026.109910.
     PubMed    
     Abstract available
     
     

133. KLEIN MM, Voskrebenzev A, Klimes F, Speth M, et al
     Phase-Resolved Functional Lung MRI-derived Pulmonary Arterial Pulse Wave Velocity Correlates with 12-Month Mortality in Participants with Pulmonary Hypertension: A Post Hoc Analysis of a Multicenter Study.
     Radiol Cardiothorac Imaging. 2026;8:e250508.
     PubMed    
     Abstract available
     
     

134. SPADAFORA L, Tahoun A, Sciarretta S
     Multimodality Imaging of Pulmonary Artery Aneurysm in Chronic Thromboembolic Pulmonary Hypertension.
     JACC Case Rep. 2026;31:109778.
     PubMed    
     
     
     

135. ZEDER K, Orasche K, John T, Douschan P, et al
     Male Sex Is Associated With Severe Pulmonary Hypertension and Worse Outcome in Chronic Obstructive Pulmonary Disease Patients Referred for Right Heart Catheterization.
     Pulm Circ. 2026;16:e70233.
     PubMed    
     Abstract available
     
     

136. WANG Z, Yi D, Zhang X, Dai J, et al
     CD133 (+) progenitor cells promote pulmonary hypertension through CXCR4 signaling.
     bioRxiv [Preprint]. 2026 Aug 2:2026.07.29.741640.
     PubMed    
     Abstract available
     
     

137. KIRIS A, Zhang P, Bronk P, Choi BR, et al
     Ventricular arrhythmogenesis in pulmonary hypertension: From right ventricular remodeling to clinical implications.
     Physiol Rep. 2026;14:e71067.
     PubMed    
     Abstract available
     
     

138. WU J, Wang J, Yang J, Rao X, et al
     Comparative evaluation of traditional and novel biomarkers for pulmonary hypertension across clinical subtypes.
     Clin Chim Acta. 2026;593:121286.
     PubMed    
     Abstract available
     
     

139. ZOU J, Zhou Y, Wang H, Jiang H, et al
     Huangqi Shengmai Decoction alleviates right ventricular hypertrophy in hypoxic pulmonary hypertension via the Src/ERK1/2 signaling pathway.
     Fitoterapia. 2026;194:107445.
     PubMed    
     Abstract available
     
     

140. LI X, Fu L, Wu W, Qu M, et al
     Impact of Internet-Based Pharmacy Care on Patient-Reported Outcomes in Congenital Heart Disease-Associated Pulmonary Hypertension in Yunnan, China.
     J Vis Exp. 2026;.
     PubMed    
     Abstract available
     
     

141. WANG Y, Ji W, Ma L, Ma X, et al
     Bibliometrics and Bioinformatics Exploration of Research Hotspots and Key Targets in Comorbidity: Interstitial Lung Disease and Pulmonary Hypertension.
     J Vis Exp. 2026;.
     PubMed    
     Abstract available
     
     

142. ZHANG Y, Zhang D, Jia W, Li Y, et al
     Clinical Relevance of Serum Inducible and Endothelial Nitric Oxide Synthase Ratio for Pulmonary Hypertension in Acute Exacerbated Chronic Obstructive Pulmonary Disease.
     Lung. 2026;204:61.
     PubMed    
     Abstract available
     
     

143. WEI Y, Zuo S, Deng N, Guo H, et al
     GLSP ameliorates monocrotaline-induced pulmonary arterial hypertension through inhibition of the PI3K/AKT and MAPK signaling pathways.
     J Mol Histol. 2026;57:275.
     PubMed    
     Abstract available
     
     

144. HARDIN EA, Dewanjee A, Davis P, Tedford RJ, et al
     Combined Post- and Precapillary Pulmonary Hypertension in Patients With Advanced Heart Failure.
     Circ Heart Fail. 2026 Aug 18:e014787. doi: 10.1161/CIRCHEARTFAILURE.126.014787.
     PubMed    
     Abstract available
     
     

145. RODIGHIERO J, Durbin J, Badalato L, Archer SL, et al
     Early Detection and Therapy of Asymptomatic Group 1 Pulmonary Hypertension Following Genetic Testing: A Case Involving Familial KCNK3 Variants.
     CJC Open. 2026;8:1060-1063.
     PubMed    
     
     
     

146. ALBULUSHI A, Shams A, Farhan H
     From Snapshot to Trajectory: The RV-3 Check for Pulmonary Arterial Hypertension Follow-up.
     Echocardiography. 2026;43:e70600.
     PubMed    
     Abstract available
     
     

147. TARAR N, Shireen Kanamgode S, Summers S
     Persistent hypoxia with mosaic attenuation despite negative CT pulmonary angiography in chronic thromboembolic pulmonary hypertension.
     BMJ Case Rep. 2026;19:e275141.
     PubMed    
     Abstract available
     
     

148. CHU KY, Lutz A
     Pulmonary Hypertension Workup Unraveling a Rare Anomaly in Turner Syndrome.
     Cureus. 2026;18:e112869.
     PubMed    
     Abstract available
     
     

149. ALI BM, Moein Auda F, Abdali Hassooni F
     Transformative Approaches to Biomarker Assessment and Clinical Profiles in Pulmonary Hypertension Patients : Short title: Biomarker Assessment and Clinical Profiles in Pulmonary Hypertension Patients.
     Galen Med J. 2025;15:e4132.
     PubMed    
     Abstract available
     
     

150. TAYA S, Ejiri K, Akagi S, Fukuda Y, et al
     Clinical phenotypes and the risk factors of mild pulmonary hypertension.
     JHLT Open. 2026;14:100628.
     PubMed    
     Abstract available
     
     

151. CHEN B, Hu J, Pan X, Fan R, et al
     Polygonum cuspidatum Exosome-Like Nanovesicles Alleviate Hypoxic Pulmonary Hypertension by Stabilizing PON1 to Inhibit MAPK-Mediated PASMC Phenotypic Switching.
     FASEB J. 2026;40:e72157.
     PubMed    
     Abstract available
     
     

152. TRIATMOJO NN, Putri VYS
     Depression and Anxiety in Pulmonary Hypertension Associated With Congenital Heart Disease: Pathophysiology and Clinical Implications of the Heart-Brain Axis.
     J Saudi Heart Assoc. 2026;38:18.
     PubMed    
     Abstract available
     
     

153. LIU Y, Kong M, Xia Y, Chen B, et al
     Keratin 17 Methyltransferasean14 Methylation Axis: A Novel Mechanism in Pulmonary Vascular Remodeling.
     J Am Heart Assoc. 2026;15:e045577.
     PubMed    
     Abstract available
     
     

154. DESROCHES-CASTAN A, Beurier-Soulat L, Tusseau M, Coulet F, et al
     Functional and Molecular Characterization of Novel GDF2 (BMP9) and BMP10 Variants From the French PAH and HHT Cohorts.
     Circ Genom Precis Med. 2026;19:e005626.
     PubMed    
     Abstract available
     
     

155. LI K, Li X
     tRNA-derived small RNAs in vascular smooth muscle cell phenotypic switching and vascular remodelling.
     Mol Biol Rep. 2026;53:1469.
     PubMed    
     Abstract available
     
     

156. ZEDER K, Wang L, Ngah V, Santi A, et al
     The Epidemiology of Pulmonary Hypertension in Sub-Saharan Africa-A Systematic Report.
     Pulm Circ. 2026;16:e70388.
     PubMed    
     Abstract available
     
     

157. CACIA MA, Imbalzano E, Vatrano M
     The Evolving Landscape of Pulmonary Vascular Disease: Current Advances and Future Directions in Pulmonary Hypertension and Pulmonary Embolism.
     Life (Basel). 2026;16:1364.
     PubMed    
     Abstract available
     
     

158. LI R, Chandler NM, Ramos-Gonzalez G, Onukwugha C, et al
     Pulmonary Hypertension and Nissen Fundoplication in Premature Infants with Bronchopulmonary Dysplasia.
     Am J Perinatol. 2026 Aug 26. doi: 10.1055/a-2941-0281.
     PubMed    
     Abstract available
     
     

159. MOHAMMED AS, Mellacheruvu SP, Gandhi Z, Lekkala SP, et al
     Factors Associated with Secondary Pulmonary Hypertension Among Hospitalized Females: An Artificial Neural Network Analysis of a National US Cohort.
     J Pers Med. 2026;16:421.
     PubMed    
     Abstract available
     
     

160. ZOLTY R
     Exercise-Induced Pulmonary Hypertension: What Is New?
     J Cardiovasc Dev Dis. 2026;13:366.
     PubMed    
     Abstract available
     
     

161. KATO S, Kodama S, Azuma M, Fukui K, et al
     Clinical Significance of Echocardiographic Parameters in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease.
     J Cardiovasc Dev Dis. 2026;13:363.
     PubMed    
     Abstract available
     
     

162. BAJPAI J, Pradhan A, Ahmad MK, Kant S, et al
     Serum Angiopoietin-1 and Angiopoietin-2 as Biomarkers of Pulmonary Hemodynamic Burden in COPD-Associated Pulmonary Hypertension: A Cross-Sectional Study.
     Adv Respir Med. 2026;94:59.
     PubMed    
     Abstract available
     
     

163. JIANG C, Liang J, Jiang X
     Bioinformatics and Machine-Learning Identification of Pulmonary Hypertension Biomarkers and Candidate Therapeutic Compounds.
     J Vis Exp. 2026;.
     PubMed    
     Abstract available
     
     

164. FORBES LM, Lahm T
     High altitude pulmonary hypertension: overlap with other types of pulmonary hypertension and implications for treatment.
     BMJ Med. 2026;5:e001786.
     PubMed    
     Abstract available
     
     

165. CHAROENPONG P, Wolf K, Banday MM, Goda Y, et al
     National prevalence and clinical impact of pulmonary hypertension in adults listed for lung retransplantation for chronic lung allograft dysfunction.
     JHLT Open. 2026;14:100651.
     PubMed    
     Abstract available
     
     

166. LU Z, Zhang C, Xiao Y, Zhao L, et al
     Risk Factors for Target Vessel Re-intervention After Balloon Pulmonary Angioplasty in Inoperable Chronic Thromboembolic Pulmonary Hypertension.
     Cardiovasc Intervent Radiol. 2026 Aug 25. doi: 10.1007/s00270-026-04361.
     PubMed    
     Abstract available
     
     

167. C K A, Jacob J, C A, Devan J, et al
     Shoshin beriberi with severe lactic acidosis and haemodynamic collapse due to long-term diuretic therapy.
     BMJ Case Rep. 2026;19:e272300.
     PubMed    
     Abstract available
     
     

168. CHANDOLA S, Chugh A, Mohan SL, Jat KR, et al
     Case 353.
     Radiology. 2026;320:e260672.
     PubMed    
     Abstract available
     
     

169. KUMAR RK, Oei JL, Madappa R, Lakshminrusimha S, et al
     Managing Neonatal Pulmonary Hypertension in Low-Resource Settings.
     J Paediatr Child Health. 2026 Aug 25. doi: 10.1111/jpc.70550.
     PubMed    
     Abstract available
     
     

170. KOSAKA S, Ochi T, Nojiri S, Okazaki T, et al
     Postoperative Pulmonary Hypertension after Primary Abdominal Wall Closure for Small Omphalocele: A Case Series.
     European J Pediatr Surg Rep. 2026;14:e45-e49.
     PubMed    
     Abstract available
     
     

171. MAO M, Huang F, Yang M, Chen L, et al
     Risk stratification and multidisciplinary management strategies for pregnancy complicated by pulmonary arterial hypertension: a narrative review.
     Front Endocrinol (Lausanne). 2026;17:1911305.
     PubMed    
     Abstract available
     
     

172. ZHANG M, Peng S, Liang N, Leng Z, et al
     Mitochondria-centered signalling in pulmonary hypertension: From metabolic reprogramming to vascular remodeling and right ventricular failure.
     Cell Signal. 2026;148:112846.
     PubMed    
     Abstract available
     
     

173. CREA F
     Focus on heart failure: Second Universal Definition, optimal potassium levels, phenotyping of pulmonary hypertension, hereditary transthyretin amyloidosis, and the challenge of a total artificial heart.
     Eur Heart J. 2026;47:4339-4345.
     PubMed    
     
     
     

174. BHATT PR, Gupta A, Ray A, Sharma A, et al
     The Silent Threat: Unmasking Combined Post- and Pre-capillary Pulmonary Hypertension (CpcPH) in an Elderly Patient With Heart Failure With Preserved Ejection Fraction (HFpEF).
     Cureus. 2026;18:e113174.
     PubMed    
     Abstract available
     
     

175. ZHENG M, Ling W, Zhang J, Ju R, et al
     Impact of the neonatal intensive critical ultrasound workflow for managing neonatal acute pulmonary hypertension.
     Front Pediatr. 2026;14:1896889.
     PubMed    
     Abstract available
     
     

176. BOCCHINO PP, Pecoraro M, Pagliassotto I, Stolfo D, et al
     Prognostic relevance of the right ventricular fractional area change to pulmonary artery systolic pressure ratio in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry.
     Int J Cardiol. 2026;462:134715.
     PubMed    
     Abstract available
     
     

177. DATAR SA, Werry N, Brown AR, Fitzpatrick DS, et al
     A large animal model of heritable pulmonary arterial hypertension using BMPR2 gene-edited sheep.
     JCI Insight. 2026;11:e205583.
     PubMed    
     Abstract available
     
     

178. REY MA, Varet S, Roche A, Ghidaglia J, et al
     Multi-organ metabolic connectivity mapping in advanced pulmonary arterial hypertension: a group-level 18 F-FDG PET-controlled study.
     BMC Med Imaging. 2026;26:423.
     PubMed    
     Abstract available
     
     

179. LU T, Zhao Y, Zhang J, Chen H, et al
     SMC4 is a hypoxia-responsive driver of pulmonary arterial hypertension through an HIF-1alpha-HDAC6-p21 regulatory axis.
     Respir Res. 2026;27:333.
     PubMed    
     Abstract available
     
     

180. SUN L, Ma N, Yu X, Fu L, et al
     Perioperative anesthetic management in pediatric patients with medically refractory pulmonary arterial hypertension undergoing surgical or transcatheter potts shunt: a retrospective case series.
     BMC Anesthesiol. 2026 Jun 16. doi: 10.1186/s12871-026-03998.
     PubMed    
     Abstract available
     
     

181. TEAWTRAKUL N, Songdej D, Hantaweepant C, Tantiworawit A, et al
     Disease-related complications and risk factors in hemoglobin H disease in a Thai multicenter registry.
     Sci Rep. 2026;16:27004.
     PubMed    
     Abstract available
     
     

182. JIANG Z, Xiao B, Hu Z, Li Y, et al
     FBXW7 ameliorates pulmonary arterial hypertension via reducing SPI1-mediated transcriptional activation of MFAP4.
     Am J Respir Cell Mol Biol. 2026;74:1297-1308.
     PubMed    
     Abstract available
     
     

183. FARMER MJS, Asghar A
     Right heart catheterization blended training program: quality improvement and educational outcomes.
     ATS Sch. 2026;7:192-200.
     PubMed    
     Abstract available
     
     

184. XU Z, Li J, Hou Y
     Clinical characteristics, predictors and prognosis of systemic sclerosis with scleroderma renal crisis and pulmonary arterial hypertension.
     Clin Exp Rheumatol. 2026;44:1582-1589.
     PubMed    
     Abstract available
     
     

185. DIR B, Mishra R, Hennen N, Mooers E, et al
     Titrating cumulative neonatal hyperoxia in mice to model bronchopulmonary dysplasia severities.
     Am J Respir Cell Mol Biol. 2026;74:1160-1169.
     PubMed    
     Abstract available
     
     

186. GHIO S, Badagliacca R, D'Alto M, Acquaro M, et al
     Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-up.
     Eur Heart J. 2026 Feb 6:ehag023. doi: 10.1093.
     PubMed    
     Abstract available
     
     

187. RADCHENKO G, Botsiuk Y, Dyadyk O, Eichstaedt CA, et al
     Pulmonary Veno-occlusive Disease in a Military Pilot: Case Report and Mini-review.
     Curr Cardiol Rev. 2026;22:e1573403X412872.
     PubMed    
     Abstract available
     
     

188. YAMAGUCHI T, Tomonari Y, Utsunomiya S, Fujioka N, et al
     Risk Factors for low Cardiac Output Syndrome in Children less than 6 years old Undergoing Ventricular Septal Defect Closure: a Retrospective Cohort Study.
     Pediatr Cardiol. 2026;47:2637-2645.
     PubMed    
     Abstract available
     
     

189. KIYOHARA Y, Sakai T, Freeman LM, Katzianer D, et al
     Pulmonary Arterial Hypertension-Targeted Therapy for Pulmonary Hypertension Associated with Left Heart Disease: Bayesian and Frequentist Meta-Analysis of Randomized Controlled Trials.
     Am J Cardiol. 2026 Aug 4:S0002-9149(26)00476.
     PubMed    
     Abstract available
     
     

190. EL-RABAHI TE, Trivedi PC, Quinn TA, Chaudhary KR, et al
     Right ventricular maladaptive functional and electrical remodeling in male Fischer rats during progressive pulmonary arterial hypertension.
     Am J Physiol Heart Circ Physiol. 2026;331:H984-H999.
     PubMed    
     Abstract available
     
     

191. ANDRUSKA AM, Cruz-Utrilla A, Nossent EJ, Celant LR, et al
     Identification of pulmonary arterial hypertension patients with venous or capillary involvement.
     Am J Respir Crit Care Med. 2026;212:2199-2210.
     PubMed    
     Abstract available
     
     

192. DAGAN M, Nanayakkara S, Chan W, Beale A, et al
     Pulmonary Hypertension Under the Microscope: What Histopathology Means for Diagnosis and Treatment.
     Chest. 2026 Jul 28:S0012-3692(26)06312-9. doi: 10.1016/j.chest.2026.07.5215.
     PubMed    
     Abstract available
     
     

193. YI L, Yao H
     Elevated Pulse Wave Amplitude Drop in Chronic Thromboembolic Pulmonary Hypertension Treated With Balloon Pulmonary Angioplasty: A Methodologic Concern on Exposure Definition.
     Chest. 2026;170:e65-e66.
     PubMed    
     
     
     

194. COUCH TJ, Hemnes AR
     Chest CT Scanning for Pulmonary Hypertension Classification in Connective Tissue Disease-Interstitial Lung Disease: One Test to Rule Them All?
     Chest. 2026;170:299-300.
     PubMed    
     
     
     

195. ULRICH S, Muller J, Furian M, Saxer S, et al
     Effects of a Sea-Level Stay on Pulmonary Hemodynamics in Patients With Pulmonary Arterial Hypertension Living in Quito Near 2,850 m.
     Chest. 2026;170:512-523.
     PubMed    
     Abstract available
     
     

196. KOLAITIS NA, Barnett CF, Chin KM, Clapham K, et al
     How to Care for the Patient With Methamphetamine-Associated Pulmonary Arterial Hypertension.
     Chest. 2026;170:524-537.
     PubMed    
     Abstract available
     
     

197. YOGESWARAN A, Funderich M, Kiely DG, Annis JS, et al
     Predictive Power of Pulmonary Artery Stiffness - Right Ventricular Interplay, but not Pulmonary Vascular Resistance, in Mild Pulmonary Hypertension: A PVRI GoDeep meta-registry analysis.
     Chest. 2026 Aug 26:S0012-3692(26)06476-7. doi: 10.1016/j.chest.2026.07.5243.
     PubMed    
     Abstract available
     
     

198. GRIFFITHS M, Chinni BK, Lokhorst C, Douwes JM, et al
     The Pediatric Pulmonary Hypertension International Risk Score: A Prediction Model for Outcomes Using Machine Learning.
     Circulation. 2026 Aug 11. doi: 10.1161/CIRCULATIONAHA.125.077391.
     PubMed    
     Abstract available
     
     

199. WANG L, Staps M, Gunther S, El Agha E, et al
     Cell Type-Specific Targeting of Different Smooth Muscle Cell Populations by Intersectional Genetics.
     Circulation. 2026;154:565-583.
     PubMed    
     Abstract available
     
     

200. ZEDER K, Kovacs G
     Current hot topics in pulmonary hypertension.
     Curr Opin Pulm Med. 2026;32:363-364.
     PubMed    
     
     
     

201. TADJKARIMI J, Lynn E, Desai S, Kouranos V, et al
     Recent updates in advanced pulmonary sarcoidosis.
     Curr Opin Pulm Med. 2026;32:491-499.
     PubMed    
     Abstract available
     
     

202. BUDHRAM B, Bonnet S, Weatherald J
     Promising signalling pathways for the treatment of pulmonary arterial hypertension.
     Curr Opin Pulm Med. 2026;32:410-423.
     PubMed    
     Abstract available
     
     

203. WEATHERALD J, Hambly N
     Shining light on a dark prognosis: prognostic factors in pulmonary hypertension associated with interstitial lung disease.
     Eur Respir J. 2026;68:2600894.
     PubMed    
     
     
     

204. FRANK BS, Beghetti M, Berger RMF, Bonnet D, et al
     Improved Outcomes with Early Aggressive Therapy in Pediatric Pulmonary Hypertension.
     Eur Respir J. 2026 Aug 6:2600327. doi: 10.1183/13993003.00327-2026.
     PubMed    
     Abstract available
     
     

205. MORRIS TA, Dakaeva K, Alotaibi M, McGuire WC, et al
     Chronic thromboembolism phenotypes after acute pulmonary embolism: identification with the SEARCH algorithm.
     Eur Respir J. 2026;68:2501562.
     PubMed    
     Abstract available
     
     

206. REDDY YNV, Frantz RP, Miranda WR, Harada T, et al
     Sotatercept in Pulmonary Arterial Hypertension: Central, Hematologic, and Peripheral Mechanisms of Benefit.
     J Am Coll Cardiol. 2026 Mar 2:S0735-1097(26)05633.
     PubMed    
     Abstract available
     
     

207. SUWA K, Kamata M
     Anesthetic Management of Transcatheter Aortic Valve Explantation 8 Years After Transcatheter Aortic Valve Replacement in a Patient with Systemic Sclerosis and Pulmonary Hypertension.
     J Cardiothorac Vasc Anesth. 2026 Aug 7:S1053-0770(26)00779.
     PubMed    
     
     
     

208. DOROBANTU DM, van de Bruaene A, Budts W, Cifra B, et al
     Sports and Supervised Exercise Programmes for Children and Young Adults with Pulmonary Hypertension. 2026 Consensus Statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN) and the Association for European Paediatric and Conge
     J Heart Lung Transplant. 2026 Jul 29:S1053-2498(26)02015.
     PubMed    
     Abstract available
     
     

209. WU Y, Deng YR, Cui XP, Zhu SS, et al
     Misdiagnosed as Idiopathic PAH: Methylmalonic Acidemia as a Reversible Cause of Pediatric Pulmonary Hypertension.
     J Heart Lung Transplant. 2026 Jul 25:S1053-2498(26)02005.
     PubMed    
     Abstract available
     
     

210. APPENZELLER P, Reddy A, Ghani H, Bambrough P, et al
     Long-term effects of medical therapy pre- and post-pulmonary endarterectomy-insights from the UK CURATE registry.
     J Heart Lung Transplant. 2026;45:1495-1505.
     PubMed    
     Abstract available
     
     

211. PHAD N, Woodford R, de Waal K
     Left ventricular diastolic dysfunction in preterm infants with bronchopulmonary dysplasia.
     J Perinatol. 2026 Jun 1. doi: 10.1038/s41372-026-02715.
     PubMed    
     Abstract available
     
     

212. ELGENDY MM, Nath S
     Pulmonary hypertension and acute hypoxic respiratory failure in preterm neonates.
     J Perinatol. 2026 Aug 8. doi: 10.1038/s41372-026-02858.
     PubMed    
     Abstract available
     
     

213. IBRAHIM J, Carr N, Verges FM, Rintoul N, et al
     ECMO use in infants with bronchopulmonary dysplasia: a literature review.
     J Perinatol. 2026 Mar 6. doi: 10.1038/s41372-025-02506.
     PubMed    
     Abstract available
     
     

214. KUMAR U, Chiu S, Chia A, Varzaly J, et al
     Safety and efficacy of a dedicated pulmonary thromboendarterectomy fellowship: The Royal Papworth experience at a high-volume center.
     J Thorac Cardiovasc Surg. 2026;172:404-412.
     PubMed    
     Abstract available
     
     

215. MCLAUGHLIN VV, Solum D, Lachant D, Ataya A, et al
     Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.
     Lancet. 2026 Jul 28:S0140-6736(26)01011-1. doi: 10.1016/S0140-6736(26)01011.
     PubMed    
     Abstract available
     
     

216. ATKINS KM, Zhang SC, Kehayias CE, Guthier C, et al
     Association of pulmonary artery radiation with pulmonary hypertension after lung cancer radiotherapy.
     Thorax. 2026 Aug 20:thorax-2025-224178. doi: 10.1136/thorax-2025-224178.
     PubMed    
     Abstract available
     
     

217. PILARD CM, Gassiat L, Cardouat G, Gauthereau I, et al
     Role of connexin 43 in hyperoxia-induced bronchopulmonary dysplasia and associated pulmonary hypertension.
     PLoS One. 2026;21:e0356364.
     PubMed    
     Abstract available